Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trial

BACKGROUND: Treatments for coronavirus disease 2019 (COVID-19) are limited by suboptimal efficacy. METHODS: From January 30, 2020 to March 23, 2020, we conducted a non-randomised controlled trial, in which all adult patients with laboratory-confirmed COVID-19 were assigned to three groups non-random...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Nannan, Guo, Lanping, Liu, Bin, Bian, Yongjun, Chen, Renbo, Chen, Suping, Chen, Yang, Chen, Yingying, Cong, Xiaodong, Dong, Guoju, Guo, Jing, Hu, Lijie, Jiang, Jianxin, Leng, Luxing, Li, Bin, Li, Dongxu, Li, Hao, Li, Jing, Li, Li, Liu, Jia, Lu, Cheng, Lv, Wenliang, Miao, Qing, Qi, Wensheng, Shi, Zhan, Shi, Jiaheng, Shi, Huaxin, Tian, Yaxin, Wang, Bing, Wang, Gang, Wang, Jian, Wang, Wei, Xian, Yongyue, Xie, Xiaolei, Xiong, Yibai, Xu, Chunyan, Xu, Ming, Yan, Bei, Yang, Jinliang, Zhang, Li, Zhou, Zhenqi, Zhu, Haoning, Huang, Luqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier GmbH. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543765/
https://www.ncbi.nlm.nih.gov/pubmed/33260064
http://dx.doi.org/10.1016/j.phymed.2020.153367

Ejemplares similares

Ejemplares similares